<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Bipolar disorder in adults: Indications for and efficacy of electroconvulsive therapy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Bipolar disorder in adults: Indications for and efficacy of electroconvulsive therapy</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Bipolar disorder in adults: Indications for and efficacy of electroconvulsive therapy</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Charles Kellner, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul Keck, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David Solomon, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 13, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H5482749"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Patients treated with electroconvulsive therapy (ECT) receive general anesthesia and muscle relaxation, followed by a small electric current administered to the scalp to produce a generalized cerebral seizure. ECT is a standard treatment for unipolar major depression; it is also used for bipolar major depression and less commonly for mania and bipolar mood episodes with mixed features. Indications for ECT include failure to respond to multiple antidepressant medication trials, or acute illness (eg, severe suicidality) that requires a rapid and definitive response. A course of ECT typically consists of 6 to 12 treatments given two or three times per week.</p><p>This topic reviews the indications and efficacy of ECT for bipolar disorder. Separate topics provide an overview of ECT (including pre-ECT evaluation, use of concurrent medications, treatment course, and adverse effects), and discuss the indications for and efficacy of ECT in unipolar major depression, the medical consultation for ECT, and the technique for performing ECT.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1709.html" rel="external">"Overview of electroconvulsive therapy (ECT) for adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1711.html" rel="external">"Unipolar major depression in adults: Indications for and efficacy of electroconvulsive therapy (ECT)"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/4817.html" rel="external">"Medical evaluation for electroconvulsive therapy"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1712.html" rel="external">"Technique for performing electroconvulsive therapy (ECT) in adults"</a>.)</p><p></p><p class="headingAnchor" id="H436125364"><span class="h1">DEFINITION OF BIPOLAR DISORDER</span><span class="headingEndMark"> — </span>Bipolar disorder is characterized by episodes of mania  (<a class="graphic graphic_table graphicRef91106" href="/d/graphic/91106.html" rel="external">table 1</a>), hypomania  (<a class="graphic graphic_table graphicRef91107" href="/d/graphic/91107.html" rel="external">table 2</a>), and major depression  (<a class="graphic graphic_table graphicRef91398" href="/d/graphic/91398.html" rel="external">table 3</a>) [<a href="#rid1">1</a>]. The subtypes of bipolar disorder include bipolar I and bipolar II. Patients with bipolar I disorder experience manic episodes and nearly always experience major depressive and hypomanic episodes. Bipolar II disorder is marked by at least one hypomanic episode, at least one major depressive episode, and the absence of manic episodes. Additional information about the clinical features and diagnosis of bipolar disorder is discussed separately. (See  <a class="medical medical_review" href="/d/html/14642.html" rel="external">"Bipolar disorder in adults: Clinical features"</a> and  <a class="medical medical_review" href="/d/html/86602.html" rel="external">"Bipolar disorder in adults: Assessment and diagnosis"</a>.)</p><p class="headingAnchor" id="H531845"><span class="h1">OVERVIEW OF ECT</span><span class="headingEndMark"> — </span>A separate topic review provides an overview of ECT, including the pre-ECT evaluation, treatment of patients with comorbid general medical illnesses, use of concurrent medications, informed consent, treatment course, adverse effects, and maintenance ECT. (See  <a class="medical medical_review" href="/d/html/1709.html" rel="external">"Overview of electroconvulsive therapy (ECT) for adults"</a>.)</p><p class="headingAnchor" id="H5482756"><span class="h1">INDICATIONS</span><span class="headingEndMark"> — </span>In bipolar disorder, as in unipolar major depression, severe symptoms in the current mood episode compel the use of electroconvulsive therapy (ECT). Treating bipolar patients with ECT is consistent with numerous practice guidelines [<a href="#rid2">2,3</a>].</p><p class="headingAnchor" id="H518772946"><span class="h2">ECT as first-line treatment</span><span class="headingEndMark"> — </span>Studies of ECT (primarily in patients with unipolar major depression) indicate that ECT provides a rapid clinical response and may thus be indicated as first-line treatment in urgent clinical situations, including [<a href="#rid4">4-8</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Severe suicidality (eg, explicit intent to carry out a well thought out suicide plan) (see  <a class="medical medical_review" href="/d/html/1708.html" rel="external">"Suicidal ideation and behavior in adults"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Severe psychosis (eg, nearly continuous auditory hallucinations commanding patients to kill themselves) (see  <a class="medical medical_review" href="/d/html/17193.html" rel="external">"Psychosis in adults: Epidemiology, clinical manifestations, and diagnostic evaluation"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Malignant catatonia – Prominent psychomotor disturbances (eg, immobility, mutism, or waxy flexibility) accompanied by fever, autonomic instability (labile or elevated blood pressure, tachycardia, tachypnea, and diaphoresis), delirium, and rigidity (see  <a class="medical medical_review" href="/d/html/14683.html" rel="external">"Catatonia in adults: Epidemiology, clinical features, assessment, and diagnosis"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Depression with fluid and food refusal that worsens general medical status due to dehydration, weight loss, and malnutrition</p><p></p><p>Administration of ECT as first-line treatment for bipolar disorder usually occurs in patients with major depression. ECT is rarely used as first-line treatment in mania because almost all of these patients receive pharmacotherapy as initial treatment. Nevertheless, manic delirium, which is rare but life threatening, is a primary indication for ECT [<a href="#rid4">4,9-11</a>].</p><p>Bilateral ECT is generally recommended in clinically urgent situations because of its greater efficacy and speed of response, compared with unilateral ECT. (See  <a class="medical medical_review" href="/d/html/1712.html" rel="external">"Technique for performing electroconvulsive therapy (ECT) in adults", section on 'Electrode placement'</a>.)</p><p class="headingAnchor" id="H518773006"><span class="h2">Medication-resistant patients</span><span class="headingEndMark"> — </span>ECT is often indicated for bipolar mood episodes that are resistant to several (eg, three to five) courses of pharmacotherapy [<a href="#rid7">7,12</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bipolar major depression</strong> – The most common indication for ECT in bipolar patients is severe major depression [<a href="#rid7">7</a>]. The risk of precipitating hypomania or mania with ECT is very low; by contrast, antidepressant medications may be problematic because of switching. (See  <a class="medical medical_review" href="/d/html/14655.html" rel="external">"Bipolar major depression in adults: Efficacy and adverse effects of antidepressants", section on 'Risk of switching to mania'</a>.)</p><p></p><p class="bulletIndent1">For patients with bipolar depression who switch to hypomania or mania during treatment with ECT, we generally continue ECT because it is effective for mania. Alternatively, it is reasonable to continue ECT and add <a class="drug drug_general" data-topicid="9566" href="/d/drug information/9566.html" rel="external">lithium</a> or a second-generation antipsychotic (eg, <a class="drug drug_general" data-topicid="9716" href="/d/drug information/9716.html" rel="external">olanzapine</a> or <a class="drug drug_general" data-topicid="9868" href="/d/drug information/9868.html" rel="external">risperidone</a>), or to discontinue ECT and start pharmacotherapy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mania</strong> – Although mania typically responds to ECT [<a href="#rid4">4,13</a>], it is used less frequently for this indication than major depression because acutely manic patients typically respond to pharmacotherapy. However, ECT may be life saving for manic delirium [<a href="#rid9">9,14,15</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bipolar mood episodes with mixed features</strong></p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rapid cycling</strong> (see  <a class="medical medical_review" href="/d/html/16890.html" rel="external">"Rapid cycling bipolar disorder in adults: Treatment of major depression", section on 'Refractory patients'</a>)</p><p></p><p>However, reserving ECT for patients who are highly resistant to pharmacotherapy may entail months or years of suffering with futile treatment [<a href="#rid7">7</a>].</p><p class="headingAnchor" id="H283521265"><span class="h1">CONTRAINDICATIONS TO ECT</span><span class="headingEndMark"> — </span>There are no absolute medical contraindications to electroconvulsive therapy (ECT) [<a href="#rid4">4</a>]. Rather, there is a relative risk benefit ratio for patients and their specific clinical situation. This is determined by assessing the seriousness and urgency of the psychiatric illness and the severity of any comorbid general medical conditions. Patients with severe general medical illnesses can usually be treated with ECT safely, when appropriate precautions are taken. (See  <a class="medical medical_review" href="/d/html/1709.html" rel="external">"Overview of electroconvulsive therapy (ECT) for adults", section on 'Patients with comorbid general medical illness'</a> and  <a class="medical medical_review" href="/d/html/4817.html" rel="external">"Medical evaluation for electroconvulsive therapy"</a>.)</p><p class="headingAnchor" id="H436125458"><span class="h1">EFFICACY</span><span class="headingEndMark"> — </span>Electroconvulsive therapy (ECT) is effective for bipolar mood episodes, including those resistant to pharmacotherapy [<a href="#rid2">2,12,16</a>].<strong> </strong>As an example, a prospective observational study included 500 patients with bipolar disorder who failed pharmacotherapy for acute mood episodes and were then treated with ECT plus pharmacotherapy (eg, antidepressants, antipsychotics, and/or <a class="drug drug_general" data-topicid="9566" href="/d/drug information/9566.html" rel="external">lithium</a>) as indicated; response (much or very much improvement) occurred in 69 percent [<a href="#rid17">17</a>]. In addition, a prospective observational study followed 70 patients with bipolar disorder (36 with major depression, 34 with a mixed episode) for a mean of 57 weeks after a successful course of acute ECT and found that approximately 60 percent had a favorable course of illness without onset of new major mood episodes [<a href="#rid18">18</a>].</p><p class="headingAnchor" id="H518772741"><span class="h2">Bipolar major depression</span><span class="headingEndMark"> — </span>Open label randomized trials suggest that for patients with bipolar major depression, ECT is superior to pharmacotherapy [<a href="#rid2">2,16</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A six-week randomized trial compared ECT with prespecified algorithm-based medications in patients who had failed two lifetime trials of pharmacotherapy (n = 66) [<a href="#rid19">19,20</a>]. ECT was administered three times per week with right unilateral electrode placement and brief pulse stimulation. The analysis per protocol found that response (reduction of baseline symptoms ≥50 percent) occurred in more patients who received ECT than medications (74 versus 35 percent). However, remission in the two groups was comparable (35 and 30 percent). It is worth noting that improvement with ECT may have been greater had bilateral electrode placement been used rather than right unilateral, but cognitive impairment may have also been greater with bilateral ECT [<a href="#rid21">21-24</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>An eight-week trial assigned patients (n = 76) to one of five treatments; marked improvement with each treatment was as follows [<a href="#rid25">25</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>ECT – 78 percent of patients</p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="8554" href="/d/drug information/8554.html" rel="external">Imipramine</a> – 59 percent</p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9762" href="/d/drug information/9762.html" rel="external">Phenelzine</a> – 45 percent</p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="8991" href="/d/drug information/8991.html" rel="external">Isocarboxazid</a> – 7 percent</p><p class="bulletIndent2"><span class="glyph">•</span>Pill placebo – 37 percent</p><p></p><p class="bulletIndent1">ECT was superior to <a class="drug drug_general" data-topicid="8991" href="/d/drug information/8991.html" rel="external">isocarboxazid</a> and placebo.</p><p></p><p>In addition, a review found that in patients with bipolar major depression (most of whom had failed pharmacotherapy), response to ECT occurred in approximately 50 to 75 percent [<a href="#rid2">2</a>]. A prospective observational study included 295 patients with bipolar major depression who failed pharmacotherapy and were then treated with ECT plus pharmacotherapy (eg, antidepressants, antipsychotics, and/or <a class="drug drug_general" data-topicid="9566" href="/d/drug information/9566.html" rel="external">lithium</a>) as indicated; response (much or very much improvement) occurred in approximately 70 percent [<a href="#rid17">17</a>]. A review conducted by the US Food and Drug Administration concluded that the evidence for treating bipolar major depression with ECT is strong [<a href="#rid26">26,27</a>].</p><p>Numerous randomized trials have demonstrated the efficacy of ECT for unipolar major depression [<a href="#rid26">26,27</a>], and observational studies suggest that symptom resolution of bipolar major depression with ECT is comparable to that of unipolar depression [<a href="#rid28">28,29</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A pooled analysis of six observational studies compared the efficacy of ECT in bipolar major depression (n = 316) with the efficacy in unipolar major depression (n = 790 patients); each study included bipolar and unipolar patients, and five studies were prospective [<a href="#rid30">30</a>]. Remission rates were similar for bipolar and unipolar patients (53 and 51 percent).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A subsequent study found that the rate of response (much or very much improved) with ECT was comparable for patients with bipolar major depression (n = 113) and patients with unipolar major depression (n = 559) (78 and 81 percent) [<a href="#rid31">31</a>].</p><p></p><p>The predictors of response to ECT in bipolar major depression are generally similar to those in unipolar depression and include the presence of psychosis, psychomotor retardation, and catatonia [<a href="#rid4">4</a>]. However, the absence of these predictors does not imply the likelihood of poor response as response to ECT in bipolar depression is excellent.</p><p>Some studies suggest that response to ECT occurs more rapidly in bipolar major depression than unipolar major depression [<a href="#rid32">32-35</a>]. However, the difference is small, and other studies have found that time to response is comparable [<a href="#rid28">28,36</a>].</p><p>Additional information about the efficacy of ECT for unipolar major depression is discussed separately. (See  <a class="medical medical_review" href="/d/html/1711.html" rel="external">"Unipolar major depression in adults: Indications for and efficacy of electroconvulsive therapy (ECT)", section on 'Efficacy'</a>.)</p><p class="headingAnchor" id="H518772731"><span class="h2">Mania</span><span class="headingEndMark"> — </span>Evidence for the efficacy of ECT for mania includes the following studies, which indicate that response occurs in approximately 80 percent of patients [<a href="#rid2">2,4,7,16,17,37</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A randomized trial compared ECT (eight bilateral treatments) plus <a class="drug drug_general" data-topicid="9252" href="/d/drug information/9252.html" rel="external">chlorpromazine</a> (600 mg per day) with simulated (sham) ECT plus chlorpromazine in 30 manic patients [<a href="#rid38">38</a>]. Improvement was greater with ECT, and the rate of recovery with ECT compared with simulated ECT was 80 percent (12 out 15 patients) versus 7 percent (1 out 15).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A review of observational (mostly retrospective) studies examined the effectiveness of ECT in a total of 589 manic patients, most of whom were resistant to pharmacotherapy [<a href="#rid39">39</a>]. Marked improvement or remission occurred in 80 percent. A subsequent retrospective study, in patients treated with ECT and concurrent antipsychotic medication (n = 33), also found that response occurred in approximately 80 percent [<a href="#rid40">40</a>].</p><p></p><p>In addition, ECT may be superior to pharmacotherapy for mania [<a href="#rid2">2</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Data drawn from two randomized trials compared ECT (n = 22 patients) with <a class="drug drug_general" data-topicid="9566" href="/d/drug information/9566.html" rel="external">lithium</a> plus <a class="drug drug_general" data-topicid="8516" href="/d/drug information/8516.html" rel="external">haloperidol</a> (n = 5) in manic patients who initially did not respond to lithium or a first-generation antipsychotic [<a href="#rid39">39,41</a>]. The rate of remission with ECT compared with lithium plus haloperidol was 59 percent (13 out of 22) versus 0 percent (0 out of 5).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A randomized trial compared ECT with <a class="drug drug_general" data-topicid="9566" href="/d/drug information/9566.html" rel="external">lithium</a> (serum concentration 0.6 to 1.5 mEq/L [0.6 to 1.5 mmol/L]) in 34 patients with mania [<a href="#rid42">42</a>]. During the first eight weeks of the study, improvement was greater with ECT; however, subsequent outcomes were comparable.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A retrospective study that compared ECT (n = 37) with <a class="drug drug_general" data-topicid="9566" href="/d/drug information/9566.html" rel="external">lithium</a> (n = 203; minimum serum concentration 0.9 mEq/L [0.9 mmol/L]) found that marked improvement occurred in more patients who received ECT (78 versus 62 percent) [<a href="#rid43">43</a>].</p><p></p><p>For patients with mania or bipolar major depression, response to ECT may be comparable. In a retrospective study, the effectiveness of ECT was similar for the following groups [<a href="#rid44">44</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Mania (n = 37 patients) – Marked improvement occurred in 78 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Bipolar major depression (n = 55) – 69 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Unipolar major depression (n = 368) – 70 percent</p><p></p><p>For patients with mania, there are no well-established predictors of response to ECT. Response may be decreased in treatment-resistant patients who have not responded to multiple medication trials, compared with patients who receive ECT as first-line treatment [<a href="#rid4">4,39</a>].</p><p class="headingAnchor" id="H518772753"><span class="h2">Mixed features</span><span class="headingEndMark"> — </span>ECT may be effective for medication-resistant bipolar mood episodes with mixed features [<a href="#rid2">2,16,45</a>]. In three prospective observational studies in patients with bipolar mixed states, response occurred in approximately 70 percent [<a href="#rid17">17,46,47</a>].</p><p class="headingAnchor" id="H518772765"><span class="h2">Rapidly cycling</span><span class="headingEndMark"> — </span>Evidence for the efficacy of ECT in treating rapid cycling bipolar patients with major depression is discussed separately. (See  <a class="medical medical_review" href="/d/html/16890.html" rel="external">"Rapid cycling bipolar disorder in adults: Treatment of major depression", section on 'Refractory patients'</a>.)</p><p class="headingAnchor" id="H518772776"><span class="h2">Peripartum patients</span><span class="headingEndMark"> — </span>ECT may be efficacious for pregnant and postpartum bipolar patients and appears to be safe for perinatal patients.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/14647.html" rel="external">"Bipolar disorder in pregnant women: Screening, diagnosis, and choosing treatment for mania and hypomania"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/17159.html" rel="external">"Teratogenicity, pregnancy complications, and postnatal risks of antipsychotics, benzodiazepines, lithium, and electroconvulsive therapy", section on 'Electroconvulsive therapy'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1712.html" rel="external">"Technique for performing electroconvulsive therapy (ECT) in adults", section on 'Pregnancy'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/83170.html" rel="external">"Bipolar disorder in postpartum women: Treatment"</a>.)</p><p></p><p class="headingAnchor" id="H5966576"><span class="h2">Maintenance treatment</span><span class="headingEndMark"> — </span>Maintenance ECT may be useful for patients unresponsive to maintenance pharmacotherapy. (See  <a class="medical medical_review" href="/d/html/680.html" rel="external">"Bipolar disorder in adults: Choosing maintenance treatment", section on 'Electroconvulsive therapy'</a>.)</p><p class="headingAnchor" id="H531677"><span class="h1">ADVERSE EFFECTS</span><span class="headingEndMark"> — </span>An overview of the adverse effects of electroconvulsive therapy (ECT) is discussed separately. (See  <a class="medical medical_review" href="/d/html/1709.html" rel="external">"Overview of electroconvulsive therapy (ECT) for adults", section on 'Adverse effects'</a>.)</p><p class="headingAnchor" id="H93289"><span class="h2">Cognitive effects</span><span class="headingEndMark"> — </span>Bipolar patients treated with ECT generally do not suffer adverse neurocognitive effects:</p><p class="bulletIndent1"><span class="glyph">●</span>A six-week randomized trial compared right unilateral ECT (high dose and brief pulse) with pharmacotherapy in patients hospitalized for bipolar major depression [<a href="#rid48">48</a>]. Seven domains of neurocognitive function were assessed, including processing speed, attention, working memory, verbal learning (anterograde memory), visual learning, reasoning, and autobiographical (retrograde) memory. Neurocognitive performance in nearly all domains improved and was comparable for the two groups. However, retrograde memory worsened in both groups, and was more impaired in the group that received ECT than medications.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A review of eight prospective studies (seven were observational) examined cognitive functioning in patients with bipolar disorder who were treated with ECT (total n = 143) [<a href="#rid29">29</a>]. The primary findings were as follows:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In studies that compared patients who received ECT with patients who received pharmacotherapy, cognitive functioning was generally comparable. Although one study found that performance on two cognitive tests was worse with ECT than pharmacotherapy, patients were not randomly assigned to treatment, and it is likely that ECT was administered to patients who were more severely ill (including patients with greater cognitive impairment).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Among patients with mania who received ECT, neuropsychological functioning after the course of treatment was generally improved from baseline.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Among patients with bipolar major depression, cognitive functioning before and after the course of ECT was comparable.</p><p></p><p>Additional information about the cognitive effects of ECT is discussed separately. (See  <a class="medical medical_review" href="/d/html/1709.html" rel="external">"Overview of electroconvulsive therapy (ECT) for adults", section on 'Adverse cognitive effects'</a>.)</p><p class="headingAnchor" id="H2318059532"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/115361.html" rel="external">"Society guideline links: Bipolar disorder"</a>.)</p><p class="headingAnchor" id="H5482806"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>Bipolar disorder is characterized by episodes of mania  (<a class="graphic graphic_table graphicRef91106" href="/d/graphic/91106.html" rel="external">table 1</a>), hypomania  (<a class="graphic graphic_table graphicRef91107" href="/d/graphic/91107.html" rel="external">table 2</a>), and major depression  (<a class="graphic graphic_table graphicRef91398" href="/d/graphic/91398.html" rel="external">table 3</a>) [<a href="#rid1">1</a>]. The subtypes of bipolar disorder include bipolar I and bipolar II. (See <a class="local">'Definition of bipolar disorder'</a> above and  <a class="medical medical_review" href="/d/html/14642.html" rel="external">"Bipolar disorder in adults: Clinical features"</a> and  <a class="medical medical_review" href="/d/html/86602.html" rel="external">"Bipolar disorder in adults: Assessment and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Clinicians prescribing electroconvulsive therapy (ECT) should be familiar with the pre-ECT evaluation, treatment of patients with comorbid general medical illnesses, use of concurrent medications, informed consent, treatment course, adverse effects of ECT, and use of maintenance ECT. (See  <a class="medical medical_review" href="/d/html/1709.html" rel="external">"Overview of electroconvulsive therapy (ECT) for adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>ECT provides a rapid clinical response and may thus be indicated as first-line treatment in urgent clinical situations, including (see <a class="local">'ECT as first-line treatment'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Severe suicidality</p><p class="bulletIndent2"><span class="glyph">•</span>Severe psychosis</p><p class="bulletIndent2"><span class="glyph">•</span>Malignant catatonia</p><p class="bulletIndent2"><span class="glyph">•</span>Depression with fluid and food refusal</p><p class="bulletIndent2"><span class="glyph">•</span>Manic delirium</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>ECT is often indicated for medication-resistant bipolar major depression, mania, and mood episodes with mixed features, based upon the apparent effectiveness of ECT for bipolar patients who do not respond to several courses of pharmacotherapy. (See <a class="local">'Medication-resistant patients'</a> above and <a class="local">'Efficacy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>There are no absolute medical contraindications to ECT; rather, there is a relative risk benefit ratio for patients and their specific clinical situation. (See <a class="local">'Contraindications to ECT'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with bipolar disorder can be safely treated with ECT. (See <a class="local">'Cognitive effects'</a> above and  <a class="medical medical_review" href="/d/html/1709.html" rel="external">"Overview of electroconvulsive therapy (ECT) for adults", section on 'Adverse effects'</a>.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), American Psychiatric Association, Arlington, VA 2013.</li><li><a class="nounderline abstract_t">Loo C, Katalinic N, Mitchell PB, Greenberg B. Physical treatments for bipolar disorder: a review of electroconvulsive therapy, stereotactic surgery and other brain stimulation techniques. J Affect Disord 2011; 132:1.</a></li><li><a class="nounderline abstract_t">Kellner CH, Goldberg JF, Briggs MC, et al. Somatic treatments for severe bipolar disorder. Lancet 2013; 382:505.</a></li><li class="breakAll">American Psychiatric Association, Task Force on Electroconvulsive Therapy. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging, American Psychiatric Association, Washington, DC 2001.</li><li><a class="nounderline abstract_t">Husain MM, Rush AJ, Fink M, et al. Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report. J Clin Psychiatry 2004; 65:485.</a></li><li><a class="nounderline abstract_t">Kellner CH, Knapp R, Husain MM, et al. Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial. Br J Psychiatry 2010; 196:226.</a></li><li><a class="nounderline abstract_t">Kellner CH, Greenberg RM, Murrough JW, et al. ECT in treatment-resistant depression. Am J Psychiatry 2012; 169:1238.</a></li><li><a class="nounderline abstract_t">Jacobowski NL, Heckers S, Bobo WV. Delirious mania: detection, diagnosis, and clinical management in the acute setting. J Psychiatr Pract 2013; 19:15.</a></li><li><a class="nounderline abstract_t">Karmacharya R, England ML, Ongür D. Delirious mania: clinical features and treatment response. J Affect Disord 2008; 109:312.</a></li><li><a class="nounderline abstract_t">Detweiler MB, Mehra A, Rowell T, et al. Delirious mania and malignant catatonia: a report of 3 cases and review. Psychiatr Q 2009; 80:23.</a></li><li><a class="nounderline abstract_t">Danivas V, Behere RV, Varambally S, et al. Electroconvulsive therapy in the treatment of delirious mania: a report of 2 patients. J ECT 2010; 26:278.</a></li><li><a class="nounderline abstract_t">Fornaro M, Carvalho AF, Fusco A, et al. The concept and management of acute episodes of treatment-resistant bipolar disorder: a systematic review and exploratory meta-analysis of randomized controlled trials. J Affect Disord 2020; 276:970.</a></li><li><a class="nounderline abstract_t">Abrams R, Taylor MA. Unipolar and bipolar depressive illness. Phenomenology and response to electroconvulsive therapy. Arch Gen Psychiatry 1974; 30:320.</a></li><li><a class="nounderline abstract_t">Small JG, Milstein V, Small IF. Electroconvulsive therapy for mania. Psychiatr Clin North Am 1991; 14:887.</a></li><li><a class="nounderline abstract_t">Small JG, Small IF, Milstein V, et al. Manic symptoms: an indication for bilateral ECT. Biol Psychiatry 1985; 20:125.</a></li><li><a class="nounderline abstract_t">Kellner CH, Ahle GM, Geduldig ET. Electroconvulsive therapy for bipolar disorder: evidence supporting what clinicians have long known. J Clin Psychiatry 2015; 76:e1151.</a></li><li><a class="nounderline abstract_t">Perugi G, Medda P, Toni C, et al. The Role of Electroconvulsive Therapy (ECT) in Bipolar Disorder: Effectiveness in 522 Patients with Bipolar Depression, Mixed-state, Mania and Catatonic Features. Curr Neuropharmacol 2017; 15:359.</a></li><li><a class="nounderline abstract_t">Medda P, Barbuti M, Novi M, et al. Naturalistic follow-up in bipolar patients after successful electroconvulsive therapy. J Affect Disord 2020; 271:152.</a></li><li><a class="nounderline abstract_t">Schoeyen HK, Kessler U, Andreassen OA, et al. Treatment-resistant bipolar depression: a randomized controlled trial of electroconvulsive therapy versus algorithm-based pharmacological treatment. Am J Psychiatry 2015; 172:41.</a></li><li><a class="nounderline abstract_t">Kessler U, Vaaler AE, Schøyen H, et al. The study protocol of the Norwegian randomized controlled trial of electroconvulsive therapy in treatment resistant depression in bipolar disorder. BMC Psychiatry 2010; 10:16.</a></li><li><a class="nounderline abstract_t">Kellner CH, Fink M. Electroconvulsive therapy versus pharmacotherapy for bipolar depression. Am J Psychiatry 2015; 172:295.</a></li><li><a class="nounderline abstract_t">Kotzalidis GD, Pacchiarotti I, Rapinesi C, et al. Differential effectiveness of right unilateral versus bilateral electroconvulsive therapy in resistant bipolar depression. Am J Psychiatry 2015; 172:294.</a></li><li><a class="nounderline abstract_t">Schoeyen HK, Kessler U, Andreassen OA, et al. Response to Kotzalidis et al. Am J Psychiatry 2015; 172:294.</a></li><li><a class="nounderline abstract_t">Schoeyen HK, Kessler U, Andreassen OA, et al. Response to Kellner and Fink. Am J Psychiatry 2015; 172:295.</a></li><li><a class="nounderline abstract_t">GREENBLATT M, GROSSER GH, WECHSLER H. DIFFERENTIAL RESPONSE OF HOSPITALIZED DEPRESSED PATIENTS TO SOMATIC THERAPY. Am J Psychiatry 1964; 120:935.</a></li><li><a class="nounderline abstract_t">Goodman WK. Electroconvulsive therapy in the spotlight. N Engl J Med 2011; 364:1785.</a></li><li class="breakAll">FDA Executive Summary: Prepared for the January 27-28, 2011 meeting of the Neurological Devices Panel. Meeting to Discuss the Classification of Electroconvulsive Therapy Devices (ECT). http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevicesAdvisoryCommittee/neurologicalDevicesPanel/UCM240933.pdf (Accessed on April 16, 2014).</li><li><a class="nounderline abstract_t">Narayanaswamy JC, Viswanath B, Reddy PV, et al. Efficacy of ECT in bipolar and unipolar depression in a real life hospital setting. Asian J Psychiatr 2014; 8:43.</a></li><li><a class="nounderline abstract_t">Versiani M, Cheniaux E, Landeira-Fernandez J. Efficacy and safety of electroconvulsive therapy in the treatment of bipolar disorder: a systematic review. J ECT 2011; 27:153.</a></li><li><a class="nounderline abstract_t">Dierckx B, Heijnen WT, van den Broek WW, Birkenhäger TK. Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: a meta-analysis. Bipolar Disord 2012; 14:146.</a></li><li><a class="nounderline abstract_t">Nordenskjöld A, von Knorring L, Engström I. Predictors of the short-term responder rate of Electroconvulsive therapy in depressive disorders--a population based study. BMC Psychiatry 2012; 12:115.</a></li><li><a class="nounderline abstract_t">Daly JJ, Prudic J, Devanand DP, et al. ECT in bipolar and unipolar depression: differences in speed of response. Bipolar Disord 2001; 3:95.</a></li><li><a class="nounderline abstract_t">Sienaert P, Vansteelandt K, Demyttenaere K, Peuskens J. Ultra-brief pulse ECT in bipolar and unipolar depressive disorder: differences in speed of response. Bipolar Disord 2009; 11:418.</a></li><li><a class="nounderline abstract_t">Sackeim HA, Prudic J. Length of the ECT course in bipolar and unipolar depression. J ECT 2005; 21:195.</a></li><li><a class="nounderline abstract_t">Scheepstra KWF, van Doorn JB, Scheepens DS, et al. 'Rapid speed of response to ECT in bipolar depression: A chart review. J Psychiatr Res 2022; 147:34.</a></li><li><a class="nounderline abstract_t">Bailine S, Fink M, Knapp R, et al. Electroconvulsive therapy is equally effective in unipolar and bipolar depression. Acta Psychiatr Scand 2010; 121:431.</a></li><li><a class="nounderline abstract_t">Fink M. ECT in therapy-resistant mania: does it have a place? Bipolar Disord 2006; 8:307.</a></li><li><a class="nounderline abstract_t">Sikdar S, Kulhara P, Avasthi A, Singh H. Combined chlorpromazine and electroconvulsive therapy in mania. Br J Psychiatry 1994; 164:806.</a></li><li><a class="nounderline abstract_t">Mukherjee S, Sackeim HA, Schnur DB. Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience. Am J Psychiatry 1994; 151:169.</a></li><li><a class="nounderline abstract_t">Wong VKH, Tor PC, Martin DM, et al. Effectiveness and Cognitive Changes With Ultrabrief Right Unilateral and Other Forms of Electroconvulsive Therapy in the Treatment of Mania. J ECT 2019; 35:40.</a></li><li><a class="nounderline abstract_t">Mukherjee S, Sackeim HA, Lee C. Unilateral ECT in the Treatment of Manic Episodes. Convuls Ther 1988; 4:74.</a></li><li><a class="nounderline abstract_t">Small JG, Klapper MH, Kellams JJ, et al. Electroconvulsive treatment compared with lithium in the management of manic states. Arch Gen Psychiatry 1988; 45:727.</a></li><li><a class="nounderline abstract_t">Black DW, Winokur G, Nasrallah A. Treatment of mania: a naturalistic study of electroconvulsive therapy versus lithium in 438 patients. J Clin Psychiatry 1987; 48:132.</a></li><li><a class="nounderline abstract_t">Black DW, Winokur G, Nasrallah A. ECT in Unipolar and Bipolar Disorders: A Naturalistic Evaluation of 460 Patients. Convuls Ther 1986; 2:231.</a></li><li><a class="nounderline abstract_t">Ciapparelli A, Dell'Osso L, Tundo A, et al. Electroconvulsive therapy in medication-nonresponsive patients with mixed mania and bipolar depression. J Clin Psychiatry 2001; 62:552.</a></li><li><a class="nounderline abstract_t">Medda P, Perugi G, Zanello S, et al. Comparative response to electroconvulsive therapy in medication-resistant bipolar I patients with depression and mixed state. J ECT 2010; 26:82.</a></li><li><a class="nounderline abstract_t">Medda P, Toni C, Mariani MG, et al. Electroconvulsive therapy in 197 patients with a severe, drug-resistant bipolar mixed state: treatment outcome and predictors of response. J Clin Psychiatry 2015; 76:1168.</a></li><li><a class="nounderline abstract_t">Kessler U, Schoeyen HK, Andreassen OA, et al. The effect of electroconvulsive therapy on neurocognitive function in treatment-resistant bipolar disorder depression. J Clin Psychiatry 2014; 75:e1306.</a></li></ol></div><div id="topicVersionRevision">Topic 14659 Version 16.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), American Psychiatric Association, Arlington, VA 2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20858566" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Physical treatments for bipolar disorder: a review of electroconvulsive therapy, stereotactic surgery and other brain stimulation techniques.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23931923" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Somatic treatments for severe bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23931923" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Somatic treatments for severe bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15119910" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20194546" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23212054" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : ECT in treatment-resistant depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23334676" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Delirious mania: detection, diagnosis, and clinical management in the acute setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18191210" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Delirious mania: clinical features and treatment response.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19199033" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Delirious mania and malignant catatonia: a report of 3 cases and review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21155154" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Electroconvulsive therapy in the treatment of delirious mania: a report of 2 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32750614" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : The concept and management of acute episodes of treatment-resistant bipolar disorder: a systematic review and exploratory meta-analysis of randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4813135" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Unipolar and bipolar depressive illness. Phenomenology and response to electroconvulsive therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1685234" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Electroconvulsive therapy for mania.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3970993" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Manic symptoms: an indication for bilateral ECT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26455688" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Electroconvulsive therapy for bipolar disorder: evidence supporting what clinicians have long known.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28503107" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The Role of Electroconvulsive Therapy (ECT) in Bipolar Disorder: Effectiveness in 522 Patients with Bipolar Depression, Mixed-state, Mania and Catatonic Features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32479311" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Naturalistic follow-up in bipolar patients after successful electroconvulsive therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25219389" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Treatment-resistant bipolar depression: a randomized controlled trial of electroconvulsive therapy versus algorithm-based pharmacological treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20178636" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The study protocol of the Norwegian randomized controlled trial of electroconvulsive therapy in treatment resistant depression in bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25727542" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Electroconvulsive therapy versus pharmacotherapy for bipolar depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25727540" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Differential effectiveness of right unilateral versus bilateral electroconvulsive therapy in resistant bipolar depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25727541" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Response to Kotzalidis et al.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25727543" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Response to Kellner and Fink.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14138843" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : DIFFERENTIAL RESPONSE OF HOSPITALIZED DEPRESSED PATIENTS TO SOMATIC THERAPY.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21561344" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Electroconvulsive therapy in the spotlight.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21561344" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Electroconvulsive therapy in the spotlight.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24655625" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Efficacy of ECT in bipolar and unipolar depression in a real life hospital setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20562714" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Efficacy and safety of electroconvulsive therapy in the treatment of bipolar disorder: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22420590" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22900754" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Predictors of the short-term responder rate of Electroconvulsive therapy in depressive disorders--a population based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11333069" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : ECT in bipolar and unipolar depression: differences in speed of response.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19500095" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Ultra-brief pulse ECT in bipolar and unipolar depressive disorder: differences in speed of response.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16127315" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Length of the ECT course in bipolar and unipolar depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35007809" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : 'Rapid speed of response to ECT in bipolar depression: A chart review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19895623" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Electroconvulsive therapy is equally effective in unipolar and bipolar depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16696837" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : ECT in therapy-resistant mania: does it have a place?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7952988" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Combined chlorpromazine and electroconvulsive therapy in mania.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8296883" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29952862" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Effectiveness and Cognitive Changes With Ultrabrief Right Unilateral and Other Forms of Electroconvulsive Therapy in the Treatment of Mania.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11940944" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Unilateral ECT in the Treatment of Manic Episodes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2899425" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Electroconvulsive treatment compared with lithium in the management of manic states.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3104316" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Treatment of mania: a naturalistic study of electroconvulsive therapy versus lithium in 438 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11940870" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : ECT in Unipolar and Bipolar Disorders: A Naturalistic Evaluation of 460 Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11488367" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Electroconvulsive therapy in medication-nonresponsive patients with mixed mania and bipolar depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19710623" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Comparative response to electroconvulsive therapy in medication-resistant bipolar I patients with depression and mixed state.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25938268" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Electroconvulsive therapy in 197 patients with a severe, drug-resistant bipolar mixed state: treatment outcome and predictors of response.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25470096" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : The effect of electroconvulsive therapy on neurocognitive function in treatment-resistant bipolar disorder depression.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
